XML 148 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Derivative Instruments
12 Months Ended
Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative instruments
Derivative Instruments
The Company enters into derivative instruments for both risk management and investment purposes. The Company is exposed to potential loss from various market risks, and manages its market risks based on guidelines established by management and the Risk and Finance Committee of the Company's Board of Directors. The Company recognizes all derivatives as either assets or liabilities in the balance sheets and measures those instruments at fair value, with the changes in fair value of derivatives shown in the consolidated statement of income as “Net realized and unrealized gains (losses) on derivative instruments” unless the derivatives are designated as hedging instruments. The accounting for derivatives that are designated as hedging instruments is described in Note 2(h), “Significant Accounting Policies – Derivative Instruments.” The following table summarizes information on the location and gross amounts of derivative fair values contained in the consolidated balance sheets at December 31, 2014 and 2013:
(U.S. dollars in thousands)
2014
 
2013
Asset
Derivative
Notional
Amount
 
Asset
Derivative
Fair
Value (1)
 
Liability
Derivative
Notional
Amount
 
Liability
Derivative
Fair
Value (1)
 
Asset
Derivative
Notional
Amount
 
Asset
Derivative
Fair
Value (1)
 
Liability
Derivative
Notional
Amount
 
Liability
Derivative
Fair
Value (1)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
2,300,609

 
$
121,862

 
$
302,211

 
$
2,936

 
$
1,005,610

 
$
26,098

 
$
2,572,227

 
$
70,462

Total derivatives designated as hedging instruments
$
2,300,609

 
$
121,862

 
$
302,211

 
$
2,936

 
$
1,005,610

 
$
26,098

 
$
2,572,227

 
$
70,462

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment Related Derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate exposure
$
394,597

 
$
206

 
$
20,782

 
$
51

 
$
30,702

 
$
266

 
$
10,259

 
$
8

Foreign exchange exposure
7,385

 
403

 
288,376

 
4,724

 
17,497

 
12

 
50,614

 
680

Credit exposure
2,408

 
165

 
14,270

 
9,836

 

 

 
340,020

 
15,128

Financial market exposure
46,145

 
360

 
33,670

 
34

 
58,232

 
1,111

 
14,821

 
77

Financial Operations Derivatives: (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit exposure

 

 

 

 

 

 
44,234

 
4,190

Other Non-Investment Derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit exposure
31,060

 
60

 

 

 

 

 

 

Guaranteed minimum income benefit contract
46,249

 
13,603

 
46,249

 
13,603

 

 

 
53,564

 
14,940

Modified coinsurance funds withheld contract (3)
64,947

 

 
5,401,278

 

 
66,369

 

 

 

Total derivatives not designated as hedging instruments
$
592,791

 
$
14,797

 
$
5,804,625

 
$
28,248

 
$
172,800

 
$
1,389

 
$
513,512

 
$
35,023

____________
(1)
Derivative instruments in an asset or liability position are included within Other assets or Other liabilities, respectively, in the balance sheets on a net basis where the Company has both a legal right of offset and the intention to settle the contracts on a net basis.
(2)
Financial operations derivatives represent interests in variable interest entities as described in Note 18, “Variable Interest Entities".
(3)
The fair value movements in derivative assets and liabilities relating to modified coinsurance funds withheld contracts are included within the associated asset or liability at each period end on the face of the balance sheets. Notional amounts associated with reinsurance agreements under which the Company assumes reinsurance risk are recorded as asset derivative notional amounts. Notional amounts associated with the Life Retro Arrangements under which the Company cedes reinsurance risk are recorded as liability derivative notional amounts. Included in the liability derivative notional amount at December 31, 2014 is the cumulative net realized and unrealized loss on life retrocession embedded derivative of $450.8 million.
The following table summarizes information on the gross and net amounts of derivative fair values and associated collateral received related to derivative assets or paid relating to derivative liabilities contained in the consolidated balance sheets at December 31, 2014 and 2013:
 
 
 
 
 
Gross Amounts Not Offset in the Balance Sheets
 
 
December 31, 2014
(U.S. dollars in thousands)
Gross Amounts Recognized in the Balance Sheets
 
Gross Amounts Offset in the Balance Sheets
 
Net Amounts in the Balance Sheets
 
Financial Instruments
 
Cash Collateral
 
Net Amounts
Derivative Assets
$
136,659

 
$
696

 
$
135,963

 
$

 
$
78,580

 
$
57,383

Derivative Liabilities
$
31,184

 
$
696

 
$
30,488

 
$

 
$

 
$
30,488

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2013
(U.S. dollars in thousands)
 
 
 
 
 
 
 
 
 
 
 
Derivative Assets
$
27,487

 
$
1,342

 
$
26,145

 
$

 
$

 
$
26,145

Derivative Liabilities
$
105,485

 
$
1,342

 
$
104,143

 
$

 
$
19,847

 
$
84,296


Derivative instruments in an asset or liability position are included within Other assets or Other liabilities, respectively, in the balance sheets on a net basis where the Company has both a legal right of offset and the intentions to settle the contracts on a net basis. The Company often enters into different types of derivative contracts with a single counterparty and these contracts are covered under netting agreements. At December 31, 2014, the Company held cash collateral related to foreign currency derivative positions and certain other derivative positions of $78.6 million. At December 31, 2013, the Company paid cash collateral related to foreign currency derivative positions and certain other derivative positions of $19.8 million. The assets and liability related to the net collateral paid or held were recorded as Other assets and Other liabilities, respectively, within the balance sheets as the collateral and derivative positions are not intended to be settled on a net basis.
(a) Derivative Instruments Designated as Fair Value Hedges
The Company designates certain of its derivative instruments as fair value hedges or cash flow hedges and formally and contemporaneously documents all relationships between the hedging instruments and hedged items and links the hedging derivative to specific assets and liabilities. The Company assesses the effectiveness of the hedge both at inception and on an on-going basis, and determines whether the hedge is highly effective in offsetting changes in fair value or cash flows of the linked hedged item.
The Company may hedge portions of its liabilities against changes in the applicable designated benchmark interest rate. Interest rate swaps may also be used to hedge the changes in fair value of certain fixed rate liabilities and fixed income securities due to changes in the designated benchmark interest rate. In addition, the Company utilizes foreign exchange contracts to hedge the fair value of certain fixed income securities as well as to hedge certain net investments in foreign operations.
The following table provides the total impact on earnings relating to derivative instruments formally designated as fair value hedges along with the impacts of the related hedged items for the years indicated:
Derivatives Designated as Fair Value Hedges
(U.S. dollars in thousands)
Hedged Items – Amount of Gain/(Loss) Recognized in Income Attributable to Risk
Gain/(Loss) Recognized in Income on Derivative
 
Deposit
Liabilities
 
Fixed
Maturity
Investments
 
Ineffective Portion of Hedging Relationship – Gain/(Loss)
Year Ended December 31, 2014
 
 
 
 
 
 
 
Interest rate exposure
$

 
 
 
 
 
 
Foreign exchange exposure
(15,663
)
 
 
 
 
 
 
Total
$
(15,663
)
 
$

 
$
15,407

 
$
(256
)
Year Ended December 31, 2013
 
 
 
 
 
 
 
Interest rate exposure
$

 
 
 
 
 
 
Foreign exchange exposure
(22,568
)
 
 
 
 
 
 
Total
$
(22,568
)
 
$

 
$
23,065

 
$
497

Year Ended December 31, 2012
 
 
 
 
 
 
 
Interest rate exposure
$
1,813

 
 
 
 
 
 
Foreign exchange exposure
(24,183
)
 
 
 
 
 
 
Total
$
(22,370
)
 
$
(6,182
)
 
$
23,967

 
$
(4,585
)

The gains (losses) recorded on both the derivative instruments and specific items designated as being hedged as part of the fair value hedging relationships outlined above along with any associated ineffectiveness in the relationships are recorded through Net realized and unrealized gains (losses) on derivative instruments in the income statement. In addition, the periodic coupon settlements relating to the interest rate swaps are recorded as adjustments to net investment income for the hedges of fixed maturity investments.
The periodic coupon settlements also resulted in decreases to Interest expense of nil, nil and $4.9 million for the years ended December 31, 2014, 2013 and 2012, respectively.
Settlement of Fair Value Hedges
A summary of the fair value hedges that have been settled and their impact on results during the indicated years ended December 31 as well as the remaining balance of fair value hedges and average years remaining to maturity are shown below:
Settlement of Fair Value Hedges – Summary
(U.S. dollars in thousands, except years)
Fair Value Hedges –
Notes Payable and Debt
December 31,
 
Fair Value Hedges –
Deposit Liabilities
December 31,
2014
 
2013
 
2014
 
2013
Cumulative reduction to interest expense
$
21,624

 
$
18,856

 
$
95,333

 
$
37,382

Remaining balance
$

 
$
2,767

 
$
137,862

 
$
195,814

Weighted average years remaining to maturity
0.0

 
0.7

 
23.2

 
22.7



During the second quarter of 2014, the Company negotiated the termination of one of its larger structured indemnity contracts. This contract had previously been designated as a fair value hedge that was settled. The remaining fair value adjustment of $47.0 million that was being amortized as a reduction of interest expense over the remaining term of the contract was recorded as an adjustment to interest expense at the termination date. As a result of the termination, a net decrease of $28.7 million was recorded to interest expense reflecting the realization of the remaining balance of the fair value hedge adjustment, partially offset by an accretion rate adjustment due to changes in cash flows.
(b) Derivative Instruments Designated as Hedges of the Net Investment in a Foreign Operation
The Company utilizes foreign exchange contracts to hedge the fair value of certain net investments in foreign operations. During the year ended December 31, 2014 and 2013, the Company entered into foreign exchange contracts that were formally designated as hedges of investments in foreign subsidiaries, the majority of which have functional currencies of either U.K. sterling or the Euro. There was no ineffectiveness in these transactions.
The following table provides the weighted average U.S. dollar equivalent of foreign denominated net assets that were hedged and the resulting derivative gain (loss) that was recorded in the foreign currency translation adjustment, net of tax, account within AOCI for the year ended December 31, 2014 and 2013.
Derivative Instruments Designated as Hedges of the Net Investment in a Foreign Operation – Summary
(U.S. dollars in thousands)
2014
 
2013
Weighted average of U.S. dollar equivalent of foreign denominated net assets
$
2,384,508

 
$
2,648,137

Derivative gains (losses) (1)
$
120,643

 
$
(27,392
)
 
____________
(1)
Derivative gains (losses) from derivative instruments designated as hedges of the net investment in a foreign operation are recorded in the cumulative translation adjustment account within AOCI for each period.
(c) Derivative Instruments Not Formally Designated As Hedging Instruments
The following table provides the total impact on earnings relating to derivative instruments not formally designated as hedging instruments under authoritative accounting guidance and from the ineffective portion of fair value hedges. The impacts are all recorded through Net realized and unrealized gains (losses) on derivatives in the income statement for the years ended December 31, 2014, 2013 and 2012:
Net Realized and Unrealized Gains (Losses) on Derivative Instruments
(U.S. dollars in thousands)
2014
 
2013
 
2012
Investment Related Derivatives:
 
 
 
 
 
Interest rate exposure
$
15,959

 
$
5,065

 
$
4,394

Foreign exchange exposure
3,351

 
(948
)
 
(1,084
)
Credit exposure
400

 
(4,052
)
 
(7,611
)
Financial market exposure
411

 
6,302

 
3,073

Financial Operations Derivatives:
 
 
 
 
 
Credit exposure
5,023

 
(2,437
)
 
10,511

Other Non-Investment Derivatives:
 
 
 
 
 
Credit exposure

 

 

Guaranteed minimum income benefit contract
2,257

 
10,457

 
(2,906
)
Modified coinsurance funds withheld contract
2,741

 
(7,086
)
 
3,429

Total derivatives not designated as hedging instruments
$
30,142

 
$
7,301

 
$
9,806

Amount of gain (loss) recognized in income from ineffective portion of fair value hedges
(256
)
 
497

 
(4,585
)
Net realized and unrealized gains (losses) on derivative instruments
$
29,886

 
$
7,798

 
$
5,221

Net realized and unrealized gains (losses on life retrocession embedded derivative and derivative instruments - Life Funds Withheld Assets
$
(488,222
)
 
$

 
$


The Company’s objectives in using these derivatives are explained below.
(d)(i) Investment Related Derivatives
The Company, either directly or through its investment managers, may use derivative instruments within its investment portfolio, including interest rate swaps, inflation swaps, commodity contracts, credit derivatives (single name and index credit default swaps), options, forward contracts and financial futures (foreign exchange, bond and stock index futures), primarily as a means of economically hedging exposures to interest rate, credit spread, equity price changes and foreign currency risk or, in limited instances, for investment purposes. When using cleared (exchange traded) derivatives, the Company is exposed to the credit risk of the applicable clearing house and of the Company's future commissions merchant. When using uncleared (over-the-counter) derivatives, the Company is exposed to credit risk in the event of non-performance by the counterparties under any derivative contracts, although the Company generally seeks to use credit support arrangements with counterparties to help manage this risk.
Investment Related Derivatives – Interest Rate Exposure
The Company utilizes risk management and overlay strategies that incorporate the use of derivative financial instruments, primarily to manage its fixed income portfolio duration and net economic exposure to interest rate risks. The Company may also use interest rate swaps to convert certain liabilities from a fixed rate to a variable rate of interest or use them to convert a variable rate of interest from one basis to another.
Investment Related Derivatives – Foreign Exchange Exposure
The Company has exposure to foreign currency exchange rate fluctuations through its operations and in its investment portfolio. The Company uses foreign exchange contracts to manage its exposure to the effects of fluctuating foreign currencies on the value of certain of its foreign currency fixed maturities. These contracts are not designated as specific hedges for financial reporting purposes and, therefore, realized and unrealized gains and losses on these contracts are recorded in income in the period in which they occur. These contracts generally have maturities of twelve months or less.
In addition, certain of the Company's investment managers may, subject to investment guidelines, enter into forward contracts.
Investment Related Derivatives – Credit Exposure
Credit derivatives may be purchased within the Company's investment portfolio in the form of single name and basket credit default swaps, which are used to mitigate credit exposure through a reduction in credit spread duration (i.e., macro credit strategies rather than single-name credit hedging) or exposure to selected issuers, including issuers that are not held in the underlying fixed income portfolio.
Investment Related Derivatives – Financial Market Exposure
Stock index futures may be purchased within the Company's investment portfolio in order to create synthetic equity exposure and to add value to the portfolio with overlay strategies where market inefficiencies are believed to exist. From time to time, the Company may enter into other financial market exposure derivative contracts on various indices including, but not limited to, inflation and commodity contracts.
(d)(ii) Financial Operations Derivatives – Credit Exposure
At December 31, 2013, the Company held one financial operations credit derivative exposure, a European project finance loan participation that benefited from a deficiency guarantee from the German state and federal governments in the amount of 68%, which was written as part of the Company's previous financial lines business and is outside of the Company's investment portfolio.
During the fourth quarter of 2014, this credit derivative exposure was terminated. The Company has no continuing financial operations derivatives credit exposure.
(d)(iii) Other Non-Investment Derivatives
Other Non-Investment Derivatives - Credit Exposure
During the year ended December 31, 2014, the Company entered into a non-investment-related credit derivative relating to a number of reference pool mortgage tranches associated with actual mortgage loans which are securitized into agency mortgage-backed securities and sold as Structured Agency Credit Risk Notes. At December 31, 2014, there was no reported event of default on this obligation. At December 31, 2014, the notional outstanding related to the derivative was $31.1 million and the Company had recorded a derivative asset of $0.1 million. During the year ended December 31, 2014, the Company recorded Net realized and unrealized gains of $0.1 million relating to this credit derivative. The credit derivative is recorded at fair value based upon models developed by the Company. Significant unobservable inputs considered in the valuation include the impact of changes in interest rates, future default, delinquency and prepayment rates, credit spreads, changes in credit quality, and other market factors.
Guaranteed Minimum Income Benefit Contract
The Company also has derivatives embedded in certain reinsurance contracts. For a certain life reinsurance contract, the Company pays the ceding company a fixed amount equal to the estimated present value of the excess of the guaranteed benefit over the account balance upon the policyholder's election to take the income benefit. The fair value of this derivative is determined based on the present value of expected cash flows.
Modified Coinsurance Funds Withheld Contract
The Company has modified coinsurance and funds withheld reinsurance agreements that provide for a return to be paid to the Company based on a portfolio of fixed income securities. As such, the agreements contain an embedded derivative. The embedded derivative is bifurcated from the funds withheld balance and recorded at fair value with changes in fair value recognized in earnings through Net realized and unrealized gains (losses) on derivative instruments.
Modified Coinsurance Funds Withheld Reinsurance Agreements - Life Retrocession Embedded Derivative
In addition, the Company has entered into Life Retro Arrangements as described in Note 2, "Significant Accounting Policies - (c) Investments - Investments Related to Life Retrocession Arrangements written on a Funds Withheld Basis" and " - (e) Reinsurance," and Note 3, "Sale of Life Reinsurance Subsidiary." The embedded derivative related to the Life Retro Arrangements is recorded at fair value with changes in fair value recognized in earnings through Net realized and unrealized gains (losses) on life retrocession embedded derivative and derivative instruments - Life Funds Withheld Assets.
The value of the life retrocession embedded derivative includes the interest income, realized and unrealized gains and losses on Life Funds Withheld Assets and certain related expenses subsequent to May 30, 2014 as follows:
Components of Life Retrocession Embedded Derivative and Derivative Instruments - Life Funds Withheld Assets:
 
(U.S. dollars in thousands)
2014
Interest income
$
(134,634
)
Realized and unrealized gains (losses) on Life Funds Withheld Assets
(318,065
)
Other
1,868

Net realized and unrealized gains (losses) on life retrocession embedded derivative
$
(450,831
)
Net adjustments related to future policy benefit reserves, net of tax
$
(21,786
)
Net realized and unrealized gains (losses) on derivative instruments - Life Funds Withheld Assets
$
(15,605
)
Net realized and unrealized gains (losses) on life retrocession embedded derivative and derivative instruments - Life Funds Withheld Assets
$
(488,222
)

(e) Contingent Credit Features
Certain derivative agreements entered into by the Company or its subsidiaries contain credit rating downgrade provisions that permit early termination of the agreements by the counterparty if collateral is not posted following failure to maintain certain credit ratings from one or more of the principal credit rating agencies. If the Company were required to early terminate such agreements due to a credit rating downgrade, it could potentially be in a net liability position at the time of settlement of such agreements. The aggregate fair value of all derivative agreements containing such rating downgrade provisions that were in a liability position and any collateral posted under these agreements at December 31 for the years indicated were as follows:
Contingent Credit Features - Summary:
(U.S. dollars in thousands)
2014
 
2013
Aggregate fair value of derivative agreements with downgrade provisions in a net liability position
$
5,770

 
$
47,703

Collateral posted to counterparty
$

 
$
13,260